Corcept (NASDAQ: CORT) director plans open-market sale of 103,606 shares
Rhea-AI Filing Summary
CORCEPT THERAPEUTICS INC (CORT) is the issuer for which director David L. Mahoney has filed a notice of proposed sale of restricted or control securities under Rule 144. The filing covers 103,606 shares of common stock held in a trust account titled “David L Mahoney & Winnifred C Ellis TR U/A DTD 06/25/1998, W Ellis & D Mahoney TTEE,” with The Charles Schwab Corporation listed as the broker. The shares were acquired through open market purchases between 05/22/2020 and 04/12/2024, and the notice is dated 08/18/2026, indicating an intention to sell these shares on the open market on or after that date, subject to Rule 144 conditions.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed for sale: 103,606 shares of common stock
Proposed aggregate market value: 12,160,257.00
Acquisition period for shares: 05/22/2020 to 04/12/2024
+1 more
4 metrics
Shares proposed for sale
103,606 shares of common stock
Number of CORT shares covered by the Rule 144 notice
Proposed aggregate market value
12,160,257.00
Stated value associated with the 103,606 common shares in the notice
Acquisition period for shares
05/22/2020 to 04/12/2024
Period during which the 103,606 shares were acquired via open market purchases
Notice date
08/18/2026
Date of the Form 144 notice of proposed sale
Key Terms
Rule 144, open market purchases, Form 144, common stock
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
open market purchases financial
"OPEN MARKET PURCHASES AQCUIRED BETWEEN: 5/22/20 - 4/12/24"
Open market purchases are buys of a company’s shares (or other securities) made on public exchanges at prevailing market prices rather than through private deals. For investors this matters because when a company buys back its own stock it reduces the number of shares available, which can boost per-share earnings and often signals management’s confidence; it also affects supply, demand and short-term liquidity much like someone quietly buying up items from a crowded marketplace.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
common stock financial
"144: Securities Information COMMON | THE CHARLES SCHWAB CORPORATION"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What does the Form 144 filing mean for CORCEPT THERAPEUTICS INC (CORT)?
A Form 144 indicates that an affiliate, director David L. Mahoney, has notified of a planned sale of 103,606 CORT common shares under Rule 144. It signals potential future insider share sales but does not guarantee that all shares will be sold.
AI-generated analysis. How Rhea-AI works. Not financial advice.
